Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 55758 results
SalvaRx, Immunova establish new JV firm Saugatuck Therapeutics
By PBR Staff Writer
SalvaRx has signed an agreement with Immunova to create a new joint venture (JV) firm Saugatuck Therapeutics.
Drug Research > Drug Discovery & Development > News
Landos Biopharma raises $10m in series A financing
Landos Biopharma, an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced that it has raised $10m in a series A financing led by life sciences investment management firm Perceptive Advisors, which will serve as its exclusive investor for the Series A round.
Drug Research > Drug Discovery & Development > News
Eleven Biotherapeutics completes Vicinium manufacturing for ongoing clinical trials in non-muscle invasive bladder cancer
Eleven Biotherapeutics announced that it has completed the manufacturing of all Vicinium necessary for its ongoing Phase 3 registration trial in patients with non-muscle invasive bladder cancer (NMIBC), and for its cooperative research and development agreement (CRADA) with the National Cancer Institute.
Contract Research & Services > Clinical Trials > News
AbbVie, Bristol-Myers to evaluate ABBV-399/Opdivo regimen in advanced solid tumors
By PBR Staff Writer
AbbVie will evaluate its investigational antibody drug conjugate, ABBV-399 (telisotuzumab vedotin), in combination with Bristol-Myers Squibb’s immunotheraphy Opdivo (nivolumab) in c-Met overexpressing non-small cell lung cancer (NSCLC).
Contract Research & Services > Clinical Trials > News
Versartis’ phase 3 Velocity trial of somavaratan in pediatric growth hormone deficiency did not meet primary endpoint
Versartis, an endocrine-focused biopharmaceutical firm that is developing somavaratan, a novel,aong-acting form of recombinant human growth hormone (rhGH) for growth hormone deficiency (GHD), announced that the Velocity Phase 3 clinical trial of somavaratan in pediatric growth hormone deficiency (GHD) did not meet its primary endpoint of non-inferiority.
Contract Research & Services > Clinical Trials > News
NSF’S New Highly Interactive Pharmaceutical Training Workshops for 2017/2018
We have listened to you and taken your feedback on board to create our new pharmaceutical training workshops for 2017/2018.
Press Releases
Almac Group Leads Economic Growth in Pennsylvania and the U.S.
Almac Group, the global contract development and manufacturing organisation, receives the spotlight for its long-term commitment to expanding its footprint in the greater Philadelphia region.
Press Releases
Almac Discovery Announce ALM201 Poster Presentation at 2017 European Society for Medical Oncology Congress
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, will present highlights of the safety data from the ALM201 Phase I trial at the ESMO congress in Madrid, Spain on September 8 – 12 2017.
Press Releases
Woodley Equipment to attend Outsourcing in Clinical Trials Nordics Conference 2017
The Clinical Trials Team at Woodley Equipment is attending Outsourcing in Clinical Trials Nordics 2017. The event is taking place on October 10th and 11th 2017 at the Crowne Plaza Copenhagen Towers Hotel, Denmark.
Contract Research & Services > Clinical Trials > Press Releases
Specialist Clinical Trials Supplier Woodley Equipment is Exhibiting at Site Solutions Summit 2017
Woodley Equipment the specialist global equipment supplier to the Clinical Trials Industry is exhibiting at Site Solutions Summit taking place at Boca Raton Resort, Florida on 6th – 8th October 2017.
Contract Research & Services > Clinical Trials > Press Releases
Merck, Pfizer get EC approval for skin cancer drug Bavencio
By PBR Staff Writer
Merck and Pfizer have secured the approval of their skin cancer drug Bavencio (avelumab) from the European Commission (EC) as a monotherapy for the treatment of metastatic Merkel cell carcinoma (mMCC) in adults.
Regulatory Affairs > News
Roche gets EC nod for Gazyvaro to treat advanced follicular lymphoma
By PBR Staff Writer
Roche has secured approval from the European Commission (EC) for its Gazyvaro (obinutuzumab) in combination with chemotherapy for the treatment for previously untreated advanced follicular lymphoma.
Regulatory Affairs > News
MilliporeSigma opens China's first end-to-end biodevelopment center in Shanghai
MilliporeSigma announced the opening of its first BioReliance end-to-end biodevelopment center in the Asia Pacific (APAC) region.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Greater Copenhagen
Greater Copenhagen is a metropolitan region that covers eastern Denmark and Skåne in southern Sweden.... Suppliers
Outsourcing in Clinical Trials Pacific Northwest
Suppliers
Outsourcing in Clinical Trials Southern California
Suppliers
Outsourcing in Clinical Trials Midwest 2017
Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Delivery > Suppliers
See more

PBR White Paper Recommendations

SHL Group: Auto Injectors - From Planning to Launch By SHL Group
Preparing for the overall development process.... Regulatory Affairs > White Papers Greater Copenhagen HealthTech Brief By Greater Copenhagen
Evolving technology and the global demand for innovative health care solutions make Greater Copenhagen the perfect location for two converging industries: life science and tech. This is your chance to get a free business brief about our HealthTech industry. In the report, you will find all the information you need about setting up a HealthTech business in Greater Copenhagen.... White Papers Cellular Technology Limited: A multicolor Natural Killer cell-mediated cytotoxicity detection By CTL Laboratories
A multicolor Natural Killer cell-mediated cytotoxicity detection using fluorescence and direct cell imaging.... Contract Research & Services > Clinical Trials > White Papers Vetter: A unique blend of expertise By Vetter Pharma International
From clinical development to commercial production.... Drug Research > Drug Delivery > White Papers Vetter Development Service - Supporting your compound’s success By Vetter Pharma International
A unique blend of expertise for clinical manufacturing.... Drug Research > Drug Delivery > White Papers See more
1-15 of 55758 results